Health

The recent case involving a Seattle-area plastic surgery provider, Allure Esthetic, and its owner Javad Sajan, MD, has shed light on the unethical practices that exist in the plastic surgery industry. Accusations of threatening patients over negative reviews, posting fake positive reviews, and enforcing illegal nondisclosure agreements have led to a federal consent decree requiring
0 Comments
A recent study conducted by Elyse Kharbanda, MD, MPH, and colleagues at the HealthPartners Institute in Bloomington, Minnesota, has found that receiving an mRNA COVID-19 vaccine during the first trimester of pregnancy does not increase the risk of major structural birth defects. This retrospective cohort study analyzed data from multiple Vaccine Safety Datalink sites and
0 Comments
The frustration expressed by Sabin Dang, MD, regarding the long waits for insurers to respond to prior authorization requests in ophthalmology raises serious concerns about the efficiency of the healthcare system. Patients deserve timely access to necessary treatments without unnecessary delays caused by administrative hurdles. Pieter Cohen, MD’s reluctance to advise patients to discontinue multivitamin
0 Comments
Recently, the Justice Department revealed a nationwide crackdown on healthcare fraud schemes that have resulted in nearly 200 individuals being charged. These individuals include doctors, nurse practitioners, and other medical professionals accused of engaging in various scams across the United States. Fraudulent claims totaling more than $2.7 billion have been uncovered, including a shocking $900
0 Comments
The Xpert HCV test and GeneXpert Xpress System have received marketing authorization from the FDA, marking a significant milestone in the diagnosis and treatment of hepatitis C virus (HCV). This point-of-care test has the potential to rapidly diagnose at-risk adults and immediately connect them to care if necessary. This groundbreaking technology is a step forward
0 Comments
A recent study presented at the American Society of Clinical Oncology annual meeting delved into the tumor immune microenvironments of triple-negative breast cancer (TNBC) at both primary and metastatic sites. The study aimed to explore how the immune composition of these tumors may influence the effectiveness of checkpoint inhibitors in treating TNBC. Dr. Yuan Yuan,
0 Comments